Phase II trial of pemetrexed for advanced chrondrosarcomas.
Latest Information Update: 18 Sep 2021
Price :
$35 *
At a glance
- Drugs Pemetrexed (Primary)
- Indications Chondrosarcoma
- Focus Therapeutic Use
- 18 Jan 2012 Biomarkers information updated
- 17 Jan 2012 Actual end date (Aug 2009) added as reported by ClinicalTrials.gov.
- 17 Jan 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.